Abstract:Genetic aberrations, such as deletions and amplifications are among the major pathogenetic mechanisms underlying malignant transformation and progression. Analysis of chromosomal aberrations is particularly important as amplifications of oncogenes and deletions of tumor suppressor genes are major steps in the “multi-hit” process of tumorigenesis. Genome-wide molecular analyses, such as loss of heterozygosity (LOH) profiling and comparative genomic hybridization (CGH) have significantly enhanced our ability to detect chromosomal aberrations in cancer cells and assess their role in tumorigenesis. The recent introduction of high-density oligonucleotide arrays capable of measuring up to 500K single nucleotide polymorphisms (SNP) loci is able to analyze small areas of gains or losses. Here we describe the use of high-density array representing upto 500K SNPs to not only characterize SNPs but also evaluate genome-wide areas of gains and losses in myeloma. We purified CD138+ myeloma cells from 5 patients and also obtained their peripheral blood mononuclear cells. Purified genomic DNA from these cells was digested with Sty and Nsp restriction enzymes, PCR amplified and hybridized to 500K SNP array. Results from DNA obtained from CD138+ myeloma cells were compared with DNA from normal peripheral blood mononuclear cells from the same patient using the dChip software for LOH and copy number analysis. Areas of deletions and amplifications were identified and correlated with gene expression profile obtained from CD138+ myeloma cells of the same patient. The preliminary analysis identified various areas of amplifications and deletions. The significant areas of structural gains or losses included Chromosome 1, 6, 8, 11, 12, 13, 14, 15, 22, X among others and ranged in size from 1 Mb to the loss of entire chromosome (13q−). In this small sample we have identified recurrent LOH shared by 2 or more samples including 1p21, 6q, 12p13 and 13q. The derived CGH results correlated with known cytogenetic abnormalities in the patients, with identification of additional areas of abnormality not detected by conventional cytogenetics or FISH. These structural changes also corresponded with the results from gene expression profiling of MM cells from same patients, thus validating the technique and its application. A large series of patient samples are now under investigation using 500K SNP chip to define regions of homozygous deletions as well as amplification. In conclusion, these results demonstrate that SNP array analysis provides a powerful new tool for the analysis of allelic imbalance in myeloma. Furthermore, this technique can identify novel candidate loci to study in pathogenesis of myeloma and advance identification of potential therapeutic targets for this fetal disease.

Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression

Screening for Candidate Genes Related to Breast Cancer with Cdna Microarray Analysis

High-Resolution Genomic And Expression Analyses Of Copy Number Alterations In Breast Tumors

Genome-wide analysis of DNA copy-number changes using cDNA microarrays

Identifying Cancer-Related Genes in Nasopharyngeal Carcinoma Cell Lines Using DNA and Mrna Expression Profiling Analyses.

A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes

Screening for Amplification Genomic Loci and Genes Associated Prognosis in Gastric Cancer

Identification and functional analysis of 9p24 amplified genes in human breast cancer

Identification of cancer genes using a statistical framework for multi-experiment analysis of non-discretized array CGH data (vol 36, pg 13, 2008)

Genetic alterations in oral squamous cell carcinoma progression detected by combining array-based comparative genomic hybridization and multiplex ligation-dependent probe amplification

Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.

Amplification of Chromosome 8q22 and Metastasis of Breast Cancers

Characterization of breast cancer by array comparative genomic hybridization.

Genomic analysis of the 8p11-12 amplicon in familial breast cancer

Concurrent gene signatures for han chinese breast cancers

Array-Based Comparative Genomic Hybridization Reveals Recurrent Chromosomal Aberrations and Jab1 As A Potential Target for 8q Gain in Hepatocellular Carcinoma

Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung

Comparative Genomic Hybridization Array Analysis and Real-Time PCR Reveals Genomic Copy Number Alteration for Lung Adenocarcinomas

Allele-Specific Amplification in Cancer Revealed by SNP Array Analysis.

Chromosomal Deletions and Amplifications in Multiple Myeloma Detected by 500k Single Nucleotide Polymorphism Array Analysis.

Development of diagnostic SCAR markers for genomic DNA amplifications in breast carcinoma by DNA cloning of high-GC RAMP-PCR fragments